Overview of NovoPen 5 Plus, NovoPen Echo, Vigipen, and KiCoPen Smart Insulin Pens
| NovoPen 5 Plus | NovoPen Echo | Vigipen | KiCoPen | |
|---|---|---|---|---|
| Company | Novo Nordisk | Novo Nordisk | Diabnext | Cambridge Consultants |
| Country of origin | United States | United States | United States | United Kingdom |
| FDA approval | No | Yes | No | No |
| U.S. availability | No | Yes | No | No |
| Cost | $68 (∼£52)* | ∼$54–$67 with discount | Unable to verify | Unable to verify |
| Insulin compatibilities | Aspart 3-mL cartridges | Aspart 3-mL cartridges | Unable to verify | Unable to verify |
| App service | No | No | Apple | Unable to verify |
| Bluetooth | No | No | Yes | Unable to verify |
| USB | No | No | No | Unable to verify |
| Features | • Records time since and dose of last injection • Displays battery life and memory status | • Designed for children • Records time since and dose of last injection • Displays battery life and memory status • Half-unit dosing | • Automatically records the time of injection as well as the amount of insulin injected • Transfers the data via Bluetooth to app | • Records time and amount injected |
↵* Currency conversions conducted on 29 January 2019.